Ovid Therapeutics Inc. (OVID) Financials

OVID Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 144.0 million 56.2 million
2023-09-30 125.0 million 23.7 million
2023-06-30 136.2 million 25.5 million
2023-03-31 143.4 million 22.4 million

OVID Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.9 million 1.8 million
2023-09-30 -10.1 million 1.6 million
2023-06-30 -11.8 million 1.9 million
2023-03-31 -12.1 million 1.9 million

OVID Net Income

No data available :(

OVID Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 105.8 million - 16.0 million
2023-09-30 87.1 million - 16.3 million
2023-06-30 96.5 million - 16.3 million
2023-03-31 117.7 million - 16.5 million

OVID Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 70.7 million
2023-09-30 70.6 million
2023-06-30 70.5 million
2023-03-31 70.5 million

OVID Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1216 10.5 million 7.7 million 300997
2023-09-30 5245 5.3 million 6.8 million -
2023-06-30 117434 6.0 million 8.2 million -
2023-03-31 13560 6.6 million 8.3 million -

OVID Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 141562 401392
2023-09-30 108972 -108.9 million
2023-06-30 75000 -74.9 million
2023-03-31 66160 -66.1 million

OVID

Price: $3.06

52 week price:
2.45
4.14

Earnings Per Share: -0.74 USD

P/E Ratio: -5.69

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 61100

Ebitda: -9.4 million

Market Capitalization: 229.8 million

Links: